Search Results - Mouhaer, S.L

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy

    Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy by Pistilli, B., Pluard, T., Urruticoechea, A., Farci, D., Kong, A., Bachelot, T., Chan, S., Han, H. S., Jerusalem, G., Urban, P., Robinson, D., Mouhaër, S. L., Tomaso, E. D., Massacesi, C., Saura, C.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    OA01.07 Capmatinib (INC280) in METΔEX14-Mutated Advanced NSCLC: Efficacy Data from the Phase 2 Geometry MONO-1 Study

    OA01.07 Capmatinib (INC280) in METΔEX14-Mutated Advanced NSCLC: Efficacy Data from the Phase 2 Geometry MONO-1 Study by Heist, R.S., Wolf, J., Seto, T., Han, J.-Y., Reguart, N., Groen, H.J.M., Tan, D.S.W., Hida, T., Jonge, M.D., Orlov, S.V., Smit, E.F., Souquet, P.-J., Vansteenkiste, J., Giovannini, M., Mouhaer, S.L., Robeva, A., Waldron-Lynch, M., Garon, E.B.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Phase II study of buparlisib

    Phase II study of buparlisib by Urban, P, Saura, C, Robinson, D, Kong, A, Pluard, T, Chan, S, Mouhaer, S.L, Farci, D, Urruticoechea, A, Bachelot, T, Pistilli, B, Jerusalem, G, Tomaso, E.D, Han, H.S, Massacesi, C

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: